BLEXTEN
Google image searchProduct monograph
Active ingredient
bilastine, 2.5 MG/ML
DIN: 02519011
Dosage form(s): SOLUTION
Route(s) of administration: ORAL
Schedule: Prescription
Company: ARALEZ PHARMACEUTICALS CANADA INC
Date: 10-FEB-2022
ATC:
- R06 — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD, )
- R06A — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD)
- R06AX — Other antihistamines for systemic use (ATC, ATC/DDD)
- R06AX29 — BILASTINE (ATC/DDD)
